AMZN
Amazon.com, Inc.
AMZN has the edge over DKNG overall, supported by stronger valuation and lower modeled downside.
DKNG
DraftKings Inc.
DKNG's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
DKNG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Stable | |
| Stable |
DKNG's revenue, cash flow and balance sheet are currently stable, but its profitability is under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
DKNG PE Valuation
DKNG has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
DKNG Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect DKNG's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over DKNG on earnings quality, reporting a profit while its opponent remains loss making.
DKNG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.77 | -$0.23 |
| Q2 2026 | -$0.35 | +$0.27 |
| Q1 2026 | $0.09 | +$0.91 |
| Q4 2025 | -$0.01 | +$1.04 |
| Q3 2025 | -$0.54 | +$0.34 |
| Q2 2025 | -$0.62 | +$0.27 |
| Q1 2025 | -$0.82 | +$0.34 |
| Q4 2024 | -$1.05 | +$0.68 |
DKNG is still losing money, but far less than before: $0.77 per share over the past year, against $4.93 at its worst in late 2021.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over DKNG on profitability, with a higher operating margin.
DKNG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +16% |
| Q2 2026 | $1.4B | -4.6% |
| Q1 2026 | $1.6B | +17% |
| Q4 2025 | $2B | +43% |
| Q3 2025 | $1.1B | +4.4% |
| Q2 2025 | $1.5B | +37% |
| Q1 2025 | $1.4B | +20% |
| Q4 2024 | $1.4B | +13% |
DKNG's revenue is growing: $1.3B last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -37% | -13 points |
| Q2 2026 | -4.7% | -15 points |
| Q1 2026 | 0.4% | +3.6 points |
| Q4 2025 | 7.6% | +18 points |
| Q3 2025 | -24% | +3.5 points |
| Q2 2025 | 10% | +13 points |
| Q1 2025 | -3.3% | +8.5 points |
| Q4 2024 | -10% | -6.4 points |
DKNG's operating margin was −37% last quarter, down 13 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
DKNG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$43.7M | -115% |
| Q2 2026 | $106.9M | -37% |
| Q1 2026 | -$55.5M | +$66.1M |
| Q4 2025 | $316.5M | -2.1% |
| Q3 2025 | $283M | +116% |
| Q2 2025 | $169.6M | +529% |
| Q1 2025 | -$121.7M | -$48.2M |
| Q4 2024 | $323.2M | +355% |
DKNG has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
DKNG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +843K shares |
| 1 year | +0.1% | +293K shares |
| 3 years | +6.9% | +32.2M shares |
| 5 years | +23% | +93.1M shares |
| Available history | +170% | +313M shares |
DKNG has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $55.6M |
| Q1 2026 | $98.6M |
| Q4 2025 | $257.6M |
| Q3 2025 | $71.2M |
| Q2 2025 | $100.5M |
| Q1 2025 | $142.3M |
| Q4 2024 | $30.1M |
DKNG spent $412M buying back its own shares over the past year, up 20% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over DKNG on leverage, with a lower net debt burden relative to earnings.
DKNG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 2.5x | Moderate |
| Q1 2026 | 0.8x | Very low |
| Q4 2025 | 0.5x | Very low |
DKNG's net debt is about 2.5 years of its operating earnings (EBITDA).
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
DKNG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 25.3 | Neutral |
DKNG's weekly RSI is 39 (neutral) and its Stochastic is 25 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
DKNG PE vs Consumer Cyclical Sector
| Metric | DKNG | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
DKNG has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over DKNG on trend strength, trading above more of its moving averages.
DKNG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $19.8 | 3.5% below |
| 20 week MA | $22.7 | 16% below |
| 50 week MA | $25.3 | 24% below |
| 100 week MA | $32.1 | 40% below |
| 200 week MA | $32.5 | 41% below |
DKNG is in a downtrend: it's below all five of its weekly moving averages, and 41% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over DKNG on returns for 2026, with the stronger performance.
DKNG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.7 | $52.1 | +388% |
| 2021 | $52.1 | $29.4 | -44% |
| 2022 | $29.4 | $11.5 | -61% |
| 2023 | $11.5 | $35.3 | +206% |
| 2024 | $35.3 | $37.9 | +7.6% |
| 2025 | $37.9 | $34.9 | -8% |
| 2026 YTD | $34.9 | $19.1 | -45% |
DKNG's yearly returns have swung widely, from +388% in 2020 to −61% in 2022. It's down 45% so far in 2026.